Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Fear of Cancer Recurrence in Cancer Survivors: a Multicentre Randomized Controlled Trial to Evaluate Internet-Based Emotional Freedom Techniques and Internet-Based Mindfulness Meditation as Intervention Strategies

NCT06175208 is registered in ClinicalTrials.gov with General Hospital Groeninge as lead sponsor.

NCT NCT06175208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06175208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Fear of Cancer Recurrence in Cancer Survivors: a Multicentre Randomized Controlled Trial to Evaluate Internet-Based Emotional Freedom Techniques and Internet-Based Mindfulness Meditation as Intervention Strategies
Lead sponsor
General Hospital Groeninge
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 3, 2024
Completion date
October 30, 2028
Enrollment
339 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

fear of cancer recurrence